Mechanical circulatory support for infarct-related cardiogenic shock: a systematic review, pairwise and network meta-analysis
Open Access
- 4 July 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (4) , oeaf091
Abstract
Aims: Mortality from cardiogenic shock complicating acute myocardial infarction (AMI-CS) remains high, despite the increasing mechanical circulatory support (MCS) use in clinical practice. Methods and results: We undertook a systematic review and meta-analysis of trials assessing MCS in adults with AMI-CS. We searched Medline, EMBASE, CENTRAL, Web of Science, and Scopus from inception to May 2024. We evaluated the effect of each intervention on early mortality using a random-effects network meta-analysis of odds ratios (ORs). Safety outcomes included stroke, bleeding, and sepsis. Fourteen trials randomizing 1858 patients were included: intra-aortic balloon pump (IABP) vs. medical therapy (four trials, n = 748 patients), veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) vs. No VA-ECMO (four trials, n = 568 patients), percutaneous ventricular assist device (pVAD) vs. No pVAD (six trials, n = 542 patients). No MCS device showed a significant effect on early mortality vs. initial medical therapy {IABP (OR 0.87, 95% CI 0.66–1.15), VA-ECMO (OR 0.91, 95% CI 0.65–1.27), pVAD (OR 0.80, 95% CI 0.56–1.14), and P (inconsistency) = 0.76}. VA-ECMO and pVAD were associated with increased major bleeding [OR 2.81 (95% CI 1.68–4.71) and OR 5.13 (95% CI 1.87–14.04), respectively]. Higher rates of stroke and sepsis were noted with pVAD. No significant safety concerns were identified with IABP. Conclusion: The mortality benefit of MCS devices in AMI-CS remains uncertain. Using such devices may be associated with increased risks, including major bleeding, stroke, and sepsis. Current evidence does not support the routine use of MCS devices in the management of AMI-CS.Keywords
This publication has 27 references indexed in Scilit:
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and ExplanationsAnnals of Internal Medicine, 2015
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic ShockNew England Journal of Medicine, 2012
- Consistency and inconsistency in network meta‐analysis: model estimation using multivariate meta‐regressionResearch Synthesis Methods, 2012
- Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shockCritical Care Medicine, 2010
- Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome*Critical Care Medicine, 2010
- A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial InfarctionJACC, 2008
- Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shockEuropean Heart Journal, 2005
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic ShockNew England Journal of Medicine, 1999
- Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarctionEuropean Heart Journal, 1993
- Clinical trial of phase-shift balloon pumping in cardiogenic shock: results in 29 patients.1969